198 related articles for article (PubMed ID: 38369542)
1. Multi-omic profiling reveals associations between the gut microbiome, host genome and transcriptome in patients with colorectal cancer.
Zou S; Yang C; Zhang J; Zhong D; Meng M; Zhang L; Chen H; Fang L
J Transl Med; 2024 Feb; 22(1):175. PubMed ID: 38369542
[TBL] [Abstract][Full Text] [Related]
2. Colorectal cancer-associated T cell receptor repertoire abnormalities are linked to gut microbiome shifts and somatic cell mutations.
Cao Y; Wang J; Hou W; Ding Y; Zhu Y; Zheng J; Huang Q; Cao Z; Xie R; Wei Q; Qin H
Gut Microbes; 2023 Dec; 15(2):2263934. PubMed ID: 37795995
[TBL] [Abstract][Full Text] [Related]
3. Meta-Analysis of Altered Gut Microbiota Reveals Microbial and Metabolic Biomarkers for Colorectal Cancer.
Avuthu N; Guda C
Microbiol Spectr; 2022 Aug; 10(4):e0001322. PubMed ID: 35766483
[TBL] [Abstract][Full Text] [Related]
4. Identification of host gene-microbiome associations in colorectal cancer patients using mendelian randomization.
Xiang Y; Zhang C; Wang J; Cheng Y; Wang L; Tong Y; Yan D
J Transl Med; 2023 Aug; 21(1):535. PubMed ID: 37563724
[TBL] [Abstract][Full Text] [Related]
5. Integrated metagenomic and metabolomic analysis reveals distinct gut-microbiome-derived phenotypes in early-onset colorectal cancer.
Kong C; Liang L; Liu G; Du L; Yang Y; Liu J; Shi D; Li X; Ma Y
Gut; 2023 Jun; 72(6):1129-1142. PubMed ID: 35953094
[TBL] [Abstract][Full Text] [Related]
6. Untangling determinants of gut microbiota and tumor immunologic status through a multi-omics approach in colorectal cancer.
Zhang SL; Cheng LS; Zhang ZY; Sun HT; Li JJ
Pharmacol Res; 2023 Feb; 188():106633. PubMed ID: 36574857
[TBL] [Abstract][Full Text] [Related]
7. Integrated analysis of intestinal microbiota and host gene expression in colorectal cancer patients.
Chen Y; Si H; Bao B; Li S; Teng D; Yan Y; Hu S; Xu Y; Du X
J Med Microbiol; 2022 Sep; 71(9):. PubMed ID: 36136380
[No Abstract] [Full Text] [Related]
8. Progress of gut microbiome and its metabolomics in early screening of colorectal cancer.
Zhou L; Jiang Z; Zhang Z; Xing J; Wang D; Tang D
Clin Transl Oncol; 2023 Jul; 25(7):1949-1962. PubMed ID: 36790675
[TBL] [Abstract][Full Text] [Related]
9. Fecal Metabolomic Signatures in Colorectal Adenoma Patients Are Associated with Gut Microbiota and Early Events of Colorectal Cancer Pathogenesis.
Kim M; Vogtmann E; Ahlquist DA; Devens ME; Kisiel JB; Taylor WR; White BA; Hale VL; Sung J; Chia N; Sinha R; Chen J
mBio; 2020 Feb; 11(1):. PubMed ID: 32071266
[TBL] [Abstract][Full Text] [Related]
10. Metformin elicits antitumour effect by modulation of the gut microbiota and rescues Fusobacterium nucleatum-induced colorectal tumourigenesis.
Huang X; Hong X; Wang J; Sun T; Yu T; Yu Y; Fang J; Xiong H
EBioMedicine; 2020 Nov; 61():103037. PubMed ID: 33039709
[TBL] [Abstract][Full Text] [Related]
11. Colorectal cancer and gut microbiota studies in China.
Wang Z; Dan W; Zhang N; Fang J; Yang Y
Gut Microbes; 2023; 15(1):2236364. PubMed ID: 37482657
[TBL] [Abstract][Full Text] [Related]
12. Multi-omic profiling reveals associations between the gut mucosal microbiome, the metabolome, and host DNA methylation associated gene expression in patients with colorectal cancer.
Wang Q; Ye J; Fang D; Lv L; Wu W; Shi D; Li Y; Yang L; Bian X; Wu J; Jiang X; Wang K; Wang Q; Hodson MP; Thibaut LM; Ho JWK; Giannoulatou E; Li L
BMC Microbiol; 2020 Apr; 20(Suppl 1):83. PubMed ID: 32321427
[TBL] [Abstract][Full Text] [Related]
13. Fusobacterium nucleatum promotes colon cancer progression by changing the mucosal microbiota and colon transcriptome in a mouse model.
Wu N; Feng YQ; Lyu N; Wang D; Yu WD; Hu YF
World J Gastroenterol; 2022 May; 28(18):1981-1995. PubMed ID: 35664967
[TBL] [Abstract][Full Text] [Related]
14. Depicting the landscape of gut microbial-metabolic interaction and microbial-host immune heterogeneity in deficient and proficient DNA mismatch repair colorectal cancers.
Li J; Guo Y; Liu J; Guo F; Du L; Yang Y; Li X; Ma Y
J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37597851
[TBL] [Abstract][Full Text] [Related]
15. The Colorectal Cancer Gut Environment Regulates Activity of the Microbiome and Promotes the Multidrug Resistant Phenotype of ESKAPE and Other Pathogens.
Lamaudière MTF; Arasaradnam R; Weedall GD; Morozov IY
mSphere; 2023 Apr; 8(2):e0062622. PubMed ID: 36847529
[TBL] [Abstract][Full Text] [Related]
16. A comprehensive analysis of the microbiota composition and gene expression in colorectal cancer.
Zhang Q; Zhao H; Wu D; Cao D; Ma W
BMC Microbiol; 2020 Oct; 20(1):308. PubMed ID: 33050883
[TBL] [Abstract][Full Text] [Related]
17. Gut microbiota dysbiosis signature is associated with the colorectal carcinogenesis sequence and improves the diagnosis of colorectal lesions.
Gao R; Wang Z; Li H; Cao Z; Gao Z; Chen H; Zhang X; Pan D; Yang R; Zhong H; Shen R; Yin L; Jia Z; Shen T; Qin N; Hu Z; Qin H
J Gastroenterol Hepatol; 2020 Dec; 35(12):2109-2121. PubMed ID: 32337748
[TBL] [Abstract][Full Text] [Related]
18. Disease-associated gut microbiome and critical metabolomic alterations in patients with colorectal cancer.
Zhang H; Jin K; Xiong K; Jing W; Pang Z; Feng M; Cheng X
Cancer Med; 2023 Jul; 12(14):15720-15735. PubMed ID: 37260140
[TBL] [Abstract][Full Text] [Related]
19. Gut Microbiome in Colorectal Cancer: Clinical Diagnosis and Treatment.
Liu Y; Lau HC; Cheng WY; Yu J
Genomics Proteomics Bioinformatics; 2023 Feb; 21(1):84-96. PubMed ID: 35914737
[TBL] [Abstract][Full Text] [Related]
20.
Yin H; Miao Z; Wang L; Su B; Liu C; Jin Y; Wu B; Han H; Yuan X
Aging (Albany NY); 2022 Feb; 14(4):1941-1958. PubMed ID: 35212644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
